Nanopath builds an innovative in vitro diagnostics platform that aims to transform disease diagnosis, particularly for underserved populations and low-resource settings. Our focus on health equity sets us apart, ensuring that all communities have access to critical diagnostic tools that can significantly improve health outcomes.
